ArticleFrontiers in neurology2026
Revaluation of the tongue function of the modified hypoglossal-to-facial transfer: a comparative cohort study.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives: Traditional end-to-end hypoglossal-to-facial anastomosis (HFA) was a common surgical procedure for uncured severe facial palsy, however, was related to tongue dysfunction. We developed a modified hypoglossal-to-facial anastomosis (MHFA) procedure with the additional process of the anastomosis of the transected hypoglossal nerve and the ramus descendens hypoglossi, aiming to salvage the tongue function. Methods: We retrospectively collected 45 cases of MHFA in our center from January 2020 to December 2022. A comparative analysis was conducted from MHFA and 27 cases of HFA in the early stage at our center. The tongue disability index was used to evaluate the tongue function during the follow-up. Results: Baseline characteristics were comparable between HFA ( Conclusion: MHFA appears promising for reducing tongue morbidity, but its clinically relevant advantage over HFA requires prospective validation using standardized outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.